‘Striking’ findings could change asthma therapy
Study may impact how GPs manage mild cases: experts
Advice for managing mild asthma in adults could change after a study showed combination preventer-reliever inhalers prevent more severe exacerbations than usual maintenance therapy.
In the 52-week, open-label trial, those patients asked to use combination budesonide-formoterol (Symbicort) as needed had 56% fewer severe exacerbations than those asked to use twice-daily budesonide, plus salbutamol as needed.
